Lupin acquires Japanese injectables firm I'rom
This article was originally published in Scrip
Executive Summary
Lupin continues to make niche buys internationally, this time acquiring the Tokyo-based specialty injectables firm I'rom Pharmaceutical for an undisclosed sum.